Healthcare and Life Science
Local Employee Benefit Consultancy EBCam Ltd launches their 2023 survey to help companies benchmark their reward offering.
Specialist Employee Benefit consultancy EBcam Ltd, who are based out of Cambridge and Bury St Edmunds have re-launched their own employee benefit survey for 2023. The survey is free for local companies to participate in. The purpose of the survey is to enable businesses to compare thei...
Charles River Associates (CRA) Acquires bioStrategies Group, Inc.
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing ...
Vector BioPharma and iBET collaborate to develop high-throughput analytical methods and scalable processes for gene delivery
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that it has entered into a strategic, multi-phase collaboration with the Instituto de Biolog...
2023: a new year with a renewed focus for the Guardtech Group
Cleanroom construction specialists’ multi-faceted approach set to reach new levels and new audiences in 2023. ...
Astrea Bioseparations acquires Delta Precision Ltd, a leading manufacturer of chromatography columns for biomanufacturing
Cambridge, UK - Astrea Bioseparations, a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd. (“Delta Precision”), a premier manufacturer of advanced chromatography columns for the biotechnology and ph...
Ubiquigent appoints Dr Xavier Jacq to Scientific Advisory Board
Leading expert in DUB biology and drug discovery further strengthens Ubiquigent’s DUB-focused capabilities and internal pipeline Dundee, UK - Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therap...
Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs
Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a Master Service Agreement with SanegeneBio Inc., (Sanegene), a start-up company dedicated to developing novel RNAi-based medicines. The focus of the collaboration...
PhoreMost reaches milestone in a Target Discovery Alliance with Boehringer Ingelheim
PhoreMost Ltd., has triggered a milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim’s ambition to develop first-in-class therapies, to transform pat...
Spatial lung cell atlas offers insights into disease and immune function
The most comprehensive lung cell atlas to date, from the Wellcome Sanger Institute and collaborators, has revealed 11 new lung cell types and offers detailed insight into an immune process involved in fighting lung infections. ...
Cambridge health technology consultancy gears for growth with new hires
Health Tech Enterprise (HTE), a Cambridge-based health technology consultancy, has expanded its team with two strategic new hires, marking a period of ongoing growth for the company. ...